Logo

Metabolon Acquires Cogenics Icoria’s Issued and Pending Metabolomics IP

Nov 01, 2007
NEW YORK (GenomeWeb News) ― Metabolon said yesterday it has acquired metabolomics-related intellectual property from Cogenics Icoria, a Clinical Data subsidiary, for an undisclosed sum.
 
Research Triangle Park, NC-based Metabolon said it now possesses all of the metabolomics-related IP that Cogenics Icoria previously owned.
 
Clinical Data acquired Cogenics Icoria in 2005.
 
Metabolon said the new IP includes issued and pending patents related to data analysis, carcinogenicity, and biomarkers for toxicity.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.